Boston Scientific (BSX) disclosed in a regulatory filing it expects to reduce headcount as part of a global restructuring program aimed at improving cost efficiencies and supporting long-term growth.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-07-27 02:13:03
















